Protein in Urine: What It Means for Kidney Health

How do healthy kidneys handle protein?

The kidneys filter about 180 liters of blood per day. The tiny filtering units, called glomeruli, are designed to keep large molecules like proteins in the bloodstream while allowing water and small waste products to pass into urine. A healthy kidney allows only a very small amount of protein into the urine — typically less than 150 mg per day 1Ref 1National Institute of Diabetes and Digestive and Kidney Diseases (2023).Chronic Kidney Disease Tests & Diagnosis.Urine albumin-to-creatinine ratio (uACR >30 mg/g as threshold for concern), eGFR testing as standard CKD workup, urine dipstick as initial protein detection, repeat testing to confirm persistent proteinuria. Albumin is the main protein in the blood and is also the main protein measured in kidney-focused urine tests.

What does it mean when protein is found in a urine test?

When a routine urine dipstick or lab test shows protein, it falls into one of two categories:

Transient (temporary) proteinuria: Protein can appear in urine temporarily during a fever, after intense exercise, after prolonged standing (orthostatic proteinuria), during dehydration, or with a urinary tract infection. A repeat test after these conditions resolve will usually be normal 1Ref 1National Institute of Diabetes and Digestive and Kidney Diseases (2023).Chronic Kidney Disease Tests & Diagnosis.Urine albumin-to-creatinine ratio (uACR >30 mg/g as threshold for concern), eGFR testing as standard CKD workup, urine dipstick as initial protein detection, repeat testing to confirm persistent proteinuria.

Persistent proteinuria: Protein detected on two or more separate urine tests, spaced weeks apart, suggests that something structural may be affecting how the kidneys filter. This warrants further investigation 2Ref 2Levin A, Ahmed SB, Carrero JJ, et al. (KDIGO) (2024).Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.uACR classification thresholds (30–300 mg/g moderately increased; >300 severely increased); ACE inhibitors/ARBs as first-line for CKD with albuminuria; SGLT2 inhibitors recommended for diabetic and non-diabetic CKD with albuminuria; persistent proteinuria on two separate tests as CKD criterion.

The test most sensitive for early kidney disease is the urine albumin-to-creatinine ratio (uACR), which measures albumin specifically and corrects for urine concentration. The 2024 KDIGO CKD guideline classifies persistent uACR above 30 mg/g as moderately or severely increased albuminuria — a threshold that is clinically significant and should be confirmed on repeat testing 2Ref 2Levin A, Ahmed SB, Carrero JJ, et al. (KDIGO) (2024).Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.uACR classification thresholds (30–300 mg/g moderately increased; >300 severely increased); ACE inhibitors/ARBs as first-line for CKD with albuminuria; SGLT2 inhibitors recommended for diabetic and non-diabetic CKD with albuminuria; persistent proteinuria on two separate tests as CKD criterion.

What conditions cause persistent protein in the urine?

Several conditions can damage the glomeruli or the kidney's filtration barrier, allowing protein to leak 2Ref 2Levin A, Ahmed SB, Carrero JJ, et al. (KDIGO) (2024).Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.uACR classification thresholds (30–300 mg/g moderately increased; >300 severely increased); ACE inhibitors/ARBs as first-line for CKD with albuminuria; SGLT2 inhibitors recommended for diabetic and non-diabetic CKD with albuminuria; persistent proteinuria on two separate tests as CKD criterion:

• Diabetes mellitus: Diabetic kidney disease (diabetic nephropathy) is one of the leading causes of proteinuria worldwide. High blood sugar over time damages the tiny blood vessels in the kidneys. Detecting early albuminuria is a key part of diabetes monitoring.
• High blood pressure (hypertension): Chronically elevated blood pressure strains and damages the glomeruli.
• Glomerulonephritis: Inflammation of the kidney's filtering units, which can be caused by immune conditions, infections, or medications.
• Chronic kidney disease (CKD): Proteinuria is both a sign and a driver of CKD progression — the more protein leaks, the more tubular damage occurs.
• Preeclampsia in pregnancy: Sudden onset of proteinuria in pregnancy alongside high blood pressure is a serious complication requiring immediate evaluation.
• Lupus and other autoimmune diseases: Can cause lupus nephritis with significant protein loss.
• Multiple myeloma: Can produce a specific protein (Bence-Jones protein) detected in urine.

What tests will a clinician order?

After proteinuria is found on a routine dipstick, a clinician will typically:

1. Repeat the urine albumin-to-creatinine ratio (uACR) on a first-morning void sample to confirm the finding is persistent and not transient 1Ref 1National Institute of Diabetes and Digestive and Kidney Diseases (2023).Chronic Kidney Disease Tests & Diagnosis.Urine albumin-to-creatinine ratio (uACR >30 mg/g as threshold for concern), eGFR testing as standard CKD workup, urine dipstick as initial protein detection, repeat testing to confirm persistent proteinuria2Ref 2Levin A, Ahmed SB, Carrero JJ, et al. (KDIGO) (2024).Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.uACR classification thresholds (30–300 mg/g moderately increased; >300 severely increased); ACE inhibitors/ARBs as first-line for CKD with albuminuria; SGLT2 inhibitors recommended for diabetic and non-diabetic CKD with albuminuria; persistent proteinuria on two separate tests as CKD criterion. 2. Check blood creatinine and eGFR (estimated glomerular filtration rate) to assess overall kidney function. An eGFR below 60 mL/min/1.73 m² combined with albuminuria confirms CKD 2Ref 2Levin A, Ahmed SB, Carrero JJ, et al. (KDIGO) (2024).Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.uACR classification thresholds (30–300 mg/g moderately increased; >300 severely increased); ACE inhibitors/ARBs as first-line for CKD with albuminuria; SGLT2 inhibitors recommended for diabetic and non-diabetic CKD with albuminuria; persistent proteinuria on two separate tests as CKD criterion. 3. Review blood pressure — hypertension is both a cause and consequence of kidney disease. 4. Check blood glucose or HbA1c to evaluate for unrecognized or poorly controlled diabetes. 5. Urinalysis with microscopy — to look for red blood cells or casts that might suggest glomerulonephritis. 6. Consider additional tests based on findings — including a 24-hour urine collection, kidney ultrasound, or referral to nephrology for a kidney biopsy if the cause is unclear or the degree of protein loss is large.

Can proteinuria be treated?

Treating the underlying cause is the primary goal:

• Blood pressure control with ACE inhibitors or ARBs: Medications that block the renin-angiotensin-aldosterone system (ACE inhibitors or ARBs) are recommended because, beyond lowering blood pressure, they reduce protein leakage from the kidneys and slow kidney disease progression. The 2024 KDIGO guideline recommends RAS inhibitors for CKD with moderately or severely increased albuminuria 2Ref 2Levin A, Ahmed SB, Carrero JJ, et al. (KDIGO) (2024).Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.uACR classification thresholds (30–300 mg/g moderately increased; >300 severely increased); ACE inhibitors/ARBs as first-line for CKD with albuminuria; SGLT2 inhibitors recommended for diabetic and non-diabetic CKD with albuminuria; persistent proteinuria on two separate tests as CKD criterion.
• Blood sugar control in diabetes: Maintaining good glycemic control markedly reduces the risk of developing or worsening diabetic kidney disease.
• SGLT2 inhibitors: A class of medication demonstrated in randomized controlled trials to have kidney-protective effects independent of blood sugar lowering. They are now recommended in the 2024 KDIGO guideline for CKD with albuminuria in people with type 2 diabetes, and increasingly in non-diabetic CKD 2Ref 2Levin A, Ahmed SB, Carrero JJ, et al. (KDIGO) (2024).Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.uACR classification thresholds (30–300 mg/g moderately increased; >300 severely increased); ACE inhibitors/ARBs as first-line for CKD with albuminuria; SGLT2 inhibitors recommended for diabetic and non-diabetic CKD with albuminuria; persistent proteinuria on two separate tests as CKD criterion3Ref 3Heerspink HJL, Stefánsson BV, Correa-Rotter R, et al. (DAPA-CKD Trial Committees and Investigators) (2020).Dapagliflozin in Patients with Chronic Kidney Disease.DAPA-CKD trial: dapagliflozin (SGLT2 inhibitor) reduced the risk of kidney failure, decline in eGFR, and death from cardiovascular or renal causes in patients with CKD and albuminuria, including non-diabetic patients.
• Dietary adjustments: Reducing sodium intake helps control blood pressure. Protein intake may be discussed with a nephrologist or dietitian in advanced CKD.
• Treating the underlying condition in immune-mediated disease (steroids, immunosuppressants for glomerulonephritis or lupus nephritis).

The earlier proteinuria is detected and addressed, the better the chance of slowing kidney disease progression 2Ref 2Levin A, Ahmed SB, Carrero JJ, et al. (KDIGO) (2024).Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.uACR classification thresholds (30–300 mg/g moderately increased; >300 severely increased); ACE inhibitors/ARBs as first-line for CKD with albuminuria; SGLT2 inhibitors recommended for diabetic and non-diabetic CKD with albuminuria; persistent proteinuria on two separate tests as CKD criterion.

How Gale can help

A Gale primary care clinician can review your lab results, order confirmatory tests, assess your blood pressure and blood sugar, and help determine whether nephrology referral is needed. Ongoing monitoring of kidney function is something Gale coordinates as part of chronic disease management.